DHEA vs Testosterone (TRT)
A prescription hormone therapy gated behind a diagnosis, against an over-the-counter prohormone whose real evidence sits in true deficiency, not in aging or low testosterone.
Short answer
TRT has the stronger evidence for its marketed use, with approval-level evidence against human clinical data for DHEA. TRT is marketed for low testosterone, vitality and anti-aging, while DHEA is marketed for anti-aging and hormone support, with thinner evidence behind that use. On access, DHEA is sold over the counter as a supplement, while TRT is a prescription drug.
DHEA
Dehydroepiandrosterone
Real replacement value in true adrenal deficiency (and FDA-approved as intravaginal prasterone), but the anti-aging trials were negative and it barely moves healthy young men's testosterone.
Full DHEA evidence reviewTestosterone (TRT)
FDA-approved for diagnosed hypogonadism; cardiovascularly non-inferior (TRAVERSE) — but not validated for anti-aging in normal-T men.
Full Testosterone (TRT) evidence reviewDHEA vs Testosterone (TRT): head to head
- FDA status / approved use
DHEA
Sold over the counter as a supplement; vaginal prasterone (Intrarosa) FDA-approved for menopausal painful sexTestosterone (TRT)
FDA-approved for diagnosed hypogonadism; not validated for low-normal testosterone or anti-aging- Marketed for
DHEA
Anti-aging, hormone supportTestosterone (TRT)
Low testosterone, vitality, anti-aging- Outcome areas
DHEA
Testosterone / male hormones; Longevity / lifespanTestosterone (TRT)
Testosterone / male hormones; Cardiovascular; Longevity / lifespan- Evidence grade
DHEA
Clinical dataTestosterone (TRT)
FDA-approved- How it works
DHEA
Adrenal prohormone the body converts into testosterone and estrogenTestosterone (TRT)
Supplies testosterone from outside, which lowers the brain's LH and FSH signals- Route and dosing
DHEA
Oral, usually 50 mg daily in trials; also a daily vaginal insertTestosterone (TRT)
Injection, gel, patch, implanted pellet, nasal gel or oral capsule- Headline human result
DHEA
No effect on body composition, strength, or quality of life vs placebo in a 2-year 2006 trial of older adultsTestosterone (TRT)
Improved sexual function and mood but not vitality in the year-long Testosterone Trials of 790 men aged 65+- Strongest evidence
DHEA
Nair, NEJM 2006 (negative)DHEA evidence reviewPubMed 17050889Testosterone (TRT)
TRAVERSE, NEJM 2023Testosterone (TRT) evidence reviewPubMed 37326322- Key safety signal
DHEA
A hormone; caution in hormone-sensitive cancers and with hormone therapies; banned in sportTestosterone (TRT)
Suppresses sperm production; TRAVERSE found more atrial fibrillation, pulmonary embolism and acute kidney injury- How it is obtained
DHEA
Over the counter as a dietary supplementTestosterone (TRT)
Prescription drug
| DHEA | Testosterone (TRT) | |
|---|---|---|
| FDA status / approved use | Sold over the counter as a supplement; vaginal prasterone (Intrarosa) FDA-approved for menopausal painful sex | FDA-approved for diagnosed hypogonadism; not validated for low-normal testosterone or anti-aging |
| Marketed for | Anti-aging, hormone support | Low testosterone, vitality, anti-aging |
| Outcome areas | Testosterone / male hormones; Longevity / lifespan | Testosterone / male hormones; Cardiovascular; Longevity / lifespan |
| Evidence grade | Clinical data | FDA-approved |
| How it works | Adrenal prohormone the body converts into testosterone and estrogen | Supplies testosterone from outside, which lowers the brain's LH and FSH signals |
| Route and dosing | Oral, usually 50 mg daily in trials; also a daily vaginal insert | Injection, gel, patch, implanted pellet, nasal gel or oral capsule |
| Headline human result | No effect on body composition, strength, or quality of life vs placebo in a 2-year 2006 trial of older adults | Improved sexual function and mood but not vitality in the year-long Testosterone Trials of 790 men aged 65+ |
| Strongest evidence | Nair, NEJM 2006 (negative)DHEA evidence reviewPubMed 17050889 | TRAVERSE, NEJM 2023Testosterone (TRT) evidence reviewPubMed 37326322 |
| Key safety signal | A hormone; caution in hormone-sensitive cancers and with hormone therapies; banned in sport | Suppresses sperm production; TRAVERSE found more atrial fibrillation, pulmonary embolism and acute kidney injury |
| How it is obtained | Over the counter as a dietary supplement | Prescription drug |
marks a row where the two differ. “Not established” marks a cell the available evidence does not answer. Evidence grades come from our evidence matrix, which grades each molecule on the human data for the use it is marketed for.
- FDA-approved:
- Approved by the FDA for a defined indication, on the strength of pivotal human trials.
- Clinical data:
- Tested in humans — but investigational, discontinued, or proven only on a surrogate marker (not the marketed outcome).
Our verdict
These are not two versions of the same thing, and they have not been compared head to head. TRT is FDA-approved for diagnosed hypogonadism, meaning symptoms plus unequivocally and consistently low testosterone confirmed on repeat morning testing; in the Testosterone Trials it improved sexual function moderately and mood slightly, with no significant benefit for vitality, and in TRAVERSE major adverse cardiac events occurred in 7.0% of the testosterone group versus 7.3% on placebo. It also suppresses your own production and sperm output. DHEA genuinely helps people with adrenal insufficiency and is FDA-approved in one specific form, intravaginal prasterone for painful sex after menopause, but the 2-year Mayo Clinic trial found no benefit for body composition, physical performance, or quality of life, and it does not meaningfully raise a healthy young man's testosterone. DHEA is not a softer, over-the-counter version of TRT; it is also banned by WADA.
DHEA fits if
Someone with a documented DHEA deficiency, or a postmenopausal woman whose issue is painful sex and who is discussing the approved intravaginal form with a clinician.
Testosterone (TRT) fits if
A man with symptoms and unequivocally low testosterone confirmed on repeat morning labs, who understands the fertility trade-off and wants monitored therapy rather than a supplement.
DHEA vs Testosterone (TRT): common questions
- Which has stronger human evidence, DHEA or TRT?
- TRT. It has approval-level evidence (key source: TRAVERSE, NEJM 2023), while DHEA has human clinical data (key source: Nair, NEJM 2006 (negative)).
- What are the main safety concerns with DHEA and TRT?
- DHEA is a hormone; caution in hormone-sensitive cancers and with hormone therapies; banned in sport. TRT suppresses sperm production; TRAVERSE found more atrial fibrillation, pulmonary embolism and acute kidney injury.
Key studies behind each
DHEA
- Orentreich N, Brind JL, Rizer RL, Vogelman JH. (1984). Age changes and sex differences in serum dehydroepiandrosterone sulfate concentrations throughout adulthood. J Clin Endocrinol Metab. PubMed 6235241
- Arlt W, Callies F, van Vlijmen JC, et al. (1999). Dehydroepiandrosterone replacement in women with adrenal insufficiency. N Engl J Med. PubMed 10502590
- Labrie F, Archer DF, Koltun W, et al. (2016). Efficacy of intravaginal dehydroepiandrosterone (DHEA) on moderate to severe dyspareunia and vaginal dryness, symptoms of vulvovaginal atrophy, and of the genitourinary syndrome of menopause. Menopause. PubMed 26731686
- Nair KS, Rizza RA, O'Brien P, et al. (2006). DHEA in elderly women and DHEA or testosterone in elderly men. N Engl J Med. PubMed 17050889
Testosterone (TRT)
- Bhasin S, Brito JP, Cunningham GR, et al. (2018). Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. PubMed 29562364
- Snyder PJ, Bhasin S, Cunningham GR, et al. (2016). Effects of Testosterone Treatment in Older Men. N Engl J Med. PubMed 26886521
- Lincoff AM, Bhasin S, Flevaris P, et al. (2023). Cardiovascular Safety of Testosterone-Replacement Therapy. N Engl J Med. PubMed 37326322
- Wang C, Meriggiola MC, Behre HM, Page ST. (2024). Hormonal male contraception. Andrology. PubMed 39016284
The full evidence reviews
- DHEA: what the evidence actually supports
The adrenal prohormone that falls with age — with genuine value in adrenal insufficiency and an FDA-approved intravaginal use, but a disappointing anti-aging and testosterone-boosting record.
Updated August 2026
- TRT: what testosterone therapy is actually proven to do
An FDA-approved therapy for diagnosed hypogonadism — with real but moderate benefits (sexual function, mood; not vitality), cardiovascular non-inferiority in TRAVERSE, and a real fertility trade-off.
Updated August 2026
Where to get it
Where to get testosterone therapy
Testosterone and hormone-optimization telehealth services with clinician oversight and lab work. Confirm current pricing and lab requirements — and whether Testosterone therapy (TRT) fits your case — with the provider.
Disclosure: Aminoscope is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. Partners are listed first; a commission never changes what we write about a provider. How we make money.
- Peter MDPartner
TRT from a one-stop men's-health provider, with enclomiphene and GLP-1 too
- MangoRxPartner
Flat-rate injectable TRT billed month to month
DudeMedsPartnerMen who specifically want branded rather than compounded testosterone and can prepay a term
Provider reviews we publish: ARSYNL RxAVARA RxBioGlow HealthBionomy HealthDadVantage Men's HealthElitePhysiqMD